Marijuana use and testicular germ cell tumors
- PMID: 20925043
- PMCID: PMC3017734
- DOI: 10.1002/cncr.25499
Marijuana use and testicular germ cell tumors
Abstract
Background: Since the early 1970s, the incidence of testicular germ cell tumors (TGCTs) in the United States has been increasing; however, potential environmental exposures accounting for this increase have not been identified. A previous study reported a significant association between frequent and long-term current marijuana users and TGCT risk. The purpose of this study was to evaluate the relation between marijuana use and TGCTs in a hospital-based case-control study.
Methods: TGCT patients diagnosed between January 1990 and October 1996 (n = 187) and male friend controls (n = 148) were enrolled in the study. All participants were between the ages of 18 and 50 at the time of diagnosis and resided in Texas, Louisiana, Arkansas, or Oklahoma. Associations of marijuana use and TGCTs were estimated using unconditional logistic regression, adjusting for age, race, prior cryptorchidism, cigarette smoking, and alcohol intake.
Results: Overall, patients with TGCTs were more likely to be frequent marijuana users (daily or greater) compared with controls (odds ratio [OR], 2.2; 95% confidence interval [CI], 1.0-5.1). Histological-specific analyses revealed that patients with nonseminoma were significantly more likely than controls to be frequent users (OR, 3.1; 95% CI, 1.2-8.2) and long-term (≥ 10 years) users (OR, 2.4; 95% CI, 1.0-6.1).
Conclusions: The finding of an association between frequent marijuana use and TGCTs, particularly among men with nonseminoma, was consistent with the findings of a previous report. Additional studies of marijuana use and TGCTs are warranted, especially studies evaluating the role of endocannabinoid signaling and cannabinoid receptors in TGCTs.
Copyright © 2010 American Cancer Society.
Conflict of interest statement
The authors declare no conflicts of interest of financial disclosures.
Similar articles
-
Association of marijuana use and the incidence of testicular germ cell tumors.Cancer. 2009 Mar 15;115(6):1215-23. doi: 10.1002/cncr.24159. Cancer. 2009. PMID: 19204904 Free PMC article.
-
Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk.Cancer. 2012 Nov 1;118(21):5374-83. doi: 10.1002/cncr.27554. Epub 2012 Sep 10. Cancer. 2012. PMID: 22965656 Free PMC article.
-
Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant.Cancer Causes Control. 2012 Oct;23(10):1593-8. doi: 10.1007/s10552-012-0036-5. Epub 2012 Jul 28. Cancer Causes Control. 2012. PMID: 22941667 Free PMC article.
-
Testicular germ cell tumor: a comprehensive review.Cell Mol Life Sci. 2019 May;76(9):1713-1727. doi: 10.1007/s00018-019-03022-7. Epub 2019 Jan 22. Cell Mol Life Sci. 2019. PMID: 30671589 Free PMC article. Review.
-
Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.Ann N Y Acad Sci. 2007 Dec;1120:187-214. doi: 10.1196/annals.1411.000. Epub 2007 Oct 2. Ann N Y Acad Sci. 2007. PMID: 17911410 Review.
Cited by
-
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions.Arch Public Health. 2022 Mar 30;80(1):100. doi: 10.1186/s13690-022-00812-7. Arch Public Health. 2022. PMID: 35354495 Free PMC article.
-
Urological complications of illicit drug use.Nat Rev Urol. 2014 Mar;11(3):169-77. doi: 10.1038/nrurol.2014.22. Epub 2014 Feb 18. Nat Rev Urol. 2014. PMID: 24535583 Review.
-
Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.Sci Rep. 2021 Jul 6;11(1):13892. doi: 10.1038/s41598-021-93411-5. Sci Rep. 2021. PMID: 34230557 Free PMC article.
-
Shifting the Paradigm on Cannabis Safety.Cannabis Cannabinoid Res. 2022 Feb;7(1):3-10. doi: 10.1089/can.2020.0003. Epub 2020 Jun 22. Cannabis Cannabinoid Res. 2022. PMID: 33998854 Free PMC article.
-
Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management.Can Urol Assoc J. 2021 Dec;15(12):413-419. doi: 10.5489/cuaj.7198. Can Urol Assoc J. 2021. PMID: 34171211 Free PMC article. Review.
References
-
- Curado MP, Edwards BK, Shin HR, et al. Cancer Incidence in Five Continents. IX. Lyon: IARC; 2007. IARC Scientific Publications No. 160. - PubMed
-
- Horner M, Reis L, Krapcho M, et al. National Cancer Institute; Bethesda, MD: 2010. SEER Cancer Statistics Review 1975-2006. http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
-
- McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003;97:63–70. - PubMed
-
- Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol. 2006;3:532–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical